Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Surveillance of Ciprofloxacin in Pediatric Patients
NCT00761462Phase 3Completed
- Sponsor
- Bayer
- Start
- Oct 1999
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ciprofloxacin in infectious diseases, sponsored by Bayer. Started Oct 1999; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
infectious diseases
Beyond the preview
Go deeper on NCT00761462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00761462.